Skip to main content

#157695

Anti-Alpha-TgCenH3 (TgCenpA) [CenpA]

Cat. #157695

Anti-Alpha-TgCenH3 (TgCenpA) [CenpA]

Cat. #: 157695

Unit size: 100 ug

Availability: 10-12 weeks

Target: T. gondii centromeric histone 3 variant (CenH3)

Class: Monoclonal

Application: IF

Reactivity: Arabidopsis

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: University of Georgia

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Alpha-TgCenH3 (TgCenpA) [CenpA]
  • Alternate name: T. gondii centromeric histone 3 variant (CenH3)
  • Research fields: Cell biology;Microbiology
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Arabidopsis
  • Application: IF
  • Description: The phylum Apicomplexa includes various parasites that cause several human diseases including malaria and toxoplasmosis. These parasites are able to invade human hosts through a complex budding process. The budding process of Toxoplasma gondii was recently shown to require the centrocone. The centromeric histone 3 variant (CenH3) is part of this centrocone and can be visualized using the TgCenpA antibody.

Target Details

  • Target: T. gondii centromeric histone 3 variant (CenH3)
  • Target background: The phylum Apicomplexa includes various parasites that cause several human diseases including malaria and toxoplasmosis. These parasites are able to invade human hosts through a complex budding process. The budding process of Toxoplasma gondii was recently shown to require the centrocone. The centromeric histone 3 variant (CenH3) is part of this centrocone and can be visualized using the TgCenpA antibody.

Applications

  • Application: IF

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Alvarez et al. 2017. PLoS Pathog. 13(7):e1006483. PMID: 28671988.
  • Brooks et al. 2011. Proc Natl Acad Sci U S A. 108(9):3767-72. PMID: 21321216.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.